IVZ vs ZBIO · rev $3.57B vs rev $10.0M
Invesco Plc (IVZ) versus Zenas BioPharma, Inc. Common Stock (ZBIO) — a side-by-side from cached financials, not a winner call.
Invesco Plc (IVZ) is a asset management company listed on NYSE.
Zenas BioPharma, Inc. Common Stock (ZBIO) is a biotechnology company listed on US.
Latest reported IVZ revenue for 2026-06-30 was $3.57B. Net income was $558.0M. IVZ currently screens at market cap $12.76B.
Latest reported ZBIO revenue for 2025-12-31 was $10.0M. Net income was -$377.7M. Revenue was up 100.0% from 2024-12-31 to 2025-12-31. ZBIO currently screens at market cap $798.0M.
IVZ currently screens at market cap $12.76B. ZBIO currently screens at market cap $798.0M.
Not investment advice. Open the IVZ and ZBIO stock pages for the full models.
Not investment advice.